Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor

Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor

US Patent 11866503 · Granted Jan 9, 2024

Estimated economic value: $118,253,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments2025
Anti-MSR1 antibodies and methods of use thereof2025
Mice that make VL binding proteins2025
Mouse model of DITRA disease and uses thereof2025
Methods for modifying a genome2025
Compositions and methods for using bispecific antibodies to bind complement and 2025
Anti-TMPRSS6 antibodies and uses thereof2025
Human antibodies to artemin and methods of use thereof2025
Anti-FC ϵ-R1 α (FCϵR1α) antibodies, bispecific antigen-binding molecules that bi2025
Anti-FC ϵ-R1 α (FCϵR1α) antibodies, bispecific antigen-binding molecules that bi2025
Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof2025
Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof2025